Renal Transplant Outcomes in Plasma Cell Dyscrasias and AL Amyloidosis after Treatment with Daratumumab.

MLA

Mohidin, Barian, et al. “Renal Transplant Outcomes in Plasma Cell Dyscrasias and AL Amyloidosis after Treatment with Daratumumab.” Journal of Clinical Medicine, vol. 13, no. 14, July 2024, p. 4109. EBSCOhost, https://doi.org/10.3390/jcm13144109.

APA

Mohidin, B., Needleman, A., Fernando, R., Lowe, D. M., Wechalekar, A., Sheaff, M., Salama, A., & Jones, G. (2024). Renal Transplant Outcomes in Plasma Cell Dyscrasias and AL Amyloidosis after Treatment with Daratumumab. Journal of Clinical Medicine, 13(14), 4109. https://doi.org/10.3390/jcm13144109

Chicago

Mohidin, Barian, Amy Needleman, Raymond Fernando, David M. Lowe, Ashutosh Wechalekar, Michael Sheaff, Alan Salama, and Gareth Jones. 2024. “Renal Transplant Outcomes in Plasma Cell Dyscrasias and AL Amyloidosis after Treatment with Daratumumab.” Journal of Clinical Medicine 13 (14): 4109. doi:10.3390/jcm13144109.